89 related articles for article (PubMed ID: 34275472)
1. Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Alegría-Baños JA; Jiménez-López JC; Vergara-Castañeda A; de León DFC; Mohar-Betancourt A; Pérez-Montiel D; Sánchez-Domínguez G; García-Villarejo M; Olivares-Pérez C; Hernández-Constantino Á; González-Santiago A; Clara-Altamirano M; Arela-Quispe L; Prada-Ortega D
J Ovarian Res; 2021 Jul; 14(1):96. PubMed ID: 34275472
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.
AlSomairi A; Himayda S; Altelmesani A; Lee YJ; Lee JY
Gynecol Oncol; 2024 Feb; 181():155-161. PubMed ID: 38176127
[TBL] [Abstract][Full Text] [Related]
3. A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin).
Klotz DM; Link T; Wimberger P; Kuhlmann JD
Clin Chem Lab Med; 2024 Feb; 62(3):530-539. PubMed ID: 37816681
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Cancer Biomarkers in the COVID-19 Era.
Farina A; Colaiacovo F; Gianfrate M; Pucci B; Angeloni A; Anastasi E
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297598
[TBL] [Abstract][Full Text] [Related]
5. The Role of Interleukin 6 (IL6), Cancer Antigen-125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients.
Muhammad S; Azwan RJ; Rita RS; Susanti R; Yusrawati
PLoS One; 2023; 18(10):e0292282. PubMed ID: 37792745
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
Mukama T; Fortner RT; Katzke V; Hynes LC; Petrera A; Hauck SM; Johnson T; Schulze M; Schiborn C; Rostgaard-Hansen AL; Tjønneland A; Overvad K; Pérez MJS; Crous-Bou M; Chirlaque MD; Amiano P; Ardanaz E; Watts EL; Travis RC; Sacerdote C; Grioni S; Masala G; Signoriello S; Tumino R; Gram IT; Sandanger TM; Sartor H; Lundin E; Idahl A; Heath AK; Dossus L; Weiderpass E; Kaaks R
Br J Cancer; 2022 May; 126(9):1301-1309. PubMed ID: 35031764
[TBL] [Abstract][Full Text] [Related]
7. HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.
Fritz-Rdzanek A; Grzybowski W; Beta J; Durczyński A; Jakimiuk A
Oncol Lett; 2012 Sep; 4(3):385-389. PubMed ID: 22984370
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis.
Kim JH; Cho HW; Park EY; Han KH; Kim ET; Lee JK; Park SY; Armbrust R; Fotopoulou C; Lim MC
Int J Gynecol Cancer; 2023 Dec; 33(12):1913-1920. PubMed ID: 37949486
[TBL] [Abstract][Full Text] [Related]
9. Tissue biomarkers in prognostication of serous ovarian cancer following neoadjuvant chemotherapy.
Khandakar B; Mathur SR; Kumar L; Kumar S; Datta Gupta S; Iyer VK; Kalaivani M
Biomed Res Int; 2014; 2014():401245. PubMed ID: 24864239
[TBL] [Abstract][Full Text] [Related]
10. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
[TBL] [Abstract][Full Text] [Related]
11. Correlates of the preoperative level of CA125 at presentation of ovarian cancer.
Cramer DW; Vitonis AF; Welch WR; Terry KL; Goodman A; Rueda BR; Berkowitz RS
Gynecol Oncol; 2010 Dec; 119(3):462-8. PubMed ID: 20850174
[TBL] [Abstract][Full Text] [Related]
12. In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy.
Corvigno S; Badal S; Spradlin ML; Keating M; Pereira I; Stur E; Bayraktar E; Foster KI; Bateman NW; Barakat W; Darcy KM; Conrads TP; Maxwell GL; Lorenzi PL; Lutgendorf SK; Wen Y; Zhao L; Thaker PH; Goodheart MJ; Liu J; Fleming N; Lee S; Eberlin LS; Sood AK
NPJ Precis Oncol; 2023 Nov; 7(1):115. PubMed ID: 37923835
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD005343. PubMed ID: 34328210
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of serum exosomal protein ZNF587B in liquid biopsy for ovarian cancer diagnosis.
Li H; Sui T; Chen X; Gu Y; Luo X; Liu Y; He Q
Am J Cancer Res; 2024; 14(4):1904-1913. PubMed ID: 38726286
[TBL] [Abstract][Full Text] [Related]
15. Promising predictive molecular biomarkers for cervical cancer (Review).
Lizano M; Carrillo-García A; De La Cruz-Hernández E; Castro-Muñoz LJ; Contreras-Paredes A
Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38606495
[TBL] [Abstract][Full Text] [Related]
16. HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial.
Fabbro M; Lamy PJ; Touraine C; Floquet A; Ray-Coquard I; Mollevi C
Front Oncol; 2023; 13():1308630. PubMed ID: 38273857
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammatory factors and T-cell subsets in the diagnosis of recurrence in epithelial ovarian cancer patients and the effect of olaparin treatment on them.
Maowulieti G; Zhao S; Zhao M; Yuan H
Immun Inflamm Dis; 2023 Oct; 11(10):e1059. PubMed ID: 37904699
[TBL] [Abstract][Full Text] [Related]
18. Effect of different metastasis patterns on the prognosis of patients with stage III high-grade serous ovarian cancer.
Yang H; Gao D; Wang C; Jiao J; Yu X; Li X
Am J Cancer Res; 2023; 13(8):3599-3606. PubMed ID: 37693130
[TBL] [Abstract][Full Text] [Related]
19. Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer.
Mleko M; Pluta E; Pitynski K; Bodzek M; Kałamacki A; Kiprian D; Banas T
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509270
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
